GPR162 and Alzheimer disease: The analysis focused on inter-group comparisons, and the results showed that compared to the HC group, both the AD and NAD groups showed significant statistical differences in GABRD+ carrying pTau217 EVs and GPR162+ carrying pTau217 EVs (p < 0.01).